Analyst Ratings for Endologix (ELGX)
ELGX Rating Summary
ELGX Price Target Summary
- Highest: $16.00 (Oppenheimer)
- Lowest: $15.00 (BMO Capital)
- Average: $15.75
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$15.75 (+13.2%)
Avg. $ Target:
$15.75 (+13.2%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/7/2012 | BMO Capital | New Coverage | Outperform (N/A) |
15.00 (N/A) |
11.90 | 13.91 | 16.89% | Details |
| 8/9/2012 | Piper Jaffray | Upgrade | Overweight (Neutral) |
16.00 (16.00) |
12.57 | 13.91 | 10.66% | Details |
| 8/8/2012 | Sidoti | New Coverage | Buy (N/A) |
16.00 (N/A) |
12.31 | 13.91 | 13% | Details |
| 8/6/2012 | Lazard Capital | Upgrade | Buy (Neutral) |
N/A (N/A) |
11.65 | 13.91 | 19.4% | Details |
| 4/25/2011 | Stephens | Upgrade | Overweight (N/A) |
N/A (N/A) |
7.85 | 13.91 | 77.2% | Details |
| 1/14/2011 | Baird | New Coverage | Outperform (N/A) |
N/A (N/A) |
6.97 | 13.91 | 99.57% | Details |
| 12/15/2010 | Oppenheimer » Updated 10/26/2012 |
New Coverage | Outperform (N/A) |
16.00 (16.00) |
6.65 | 13.91 | 109.17% | Details |
| 12/10/2010 | Wedbush » Updated 6/3/2011 |
New Coverage | Outperform (N/A) |
N/A (N/A) |
5.75 | 13.91 | 141.91% | Details |
| 7/23/2010 | Capstone Investments | Upgrade | Buy (N/A) |
N/A (N/A) |
4.90 | 13.91 | 183.88% | Details |
